Figure 6.
Predictive response to immune checkpoint inhibitor (ICI) treatment in patients with LUAD. Relative probabilities of responding to (A) anti-PD-1/PD-L1 and (B) anti-CTLA4 treatments. The mRNA levels of (C) PD-1, (D) PD-L1, and (E) CTLA4.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.